Faralimomab
Faralimomab is a mouse monoclonal antibody and an immunomodulator.[1]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | Interferon receptor |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
![]() ![]() |
References
- "WHO Drug Information" (PDF). Archived from the original (PDF) on 2011-06-04. Retrieved 2009-09-24.
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
|
Chemokine |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSF |
| ||||||||||||
Interferon |
| ||||||||||||
Interleukin |
| ||||||||||||
TGFβ |
| ||||||||||||
TNF |
| ||||||||||||
Others |
| ||||||||||||
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.